Mkts

Aytu BioPharma, Inc.

NASDAQ: AYTU
$1.90-0.03 (-1.55%)
As of Oct 27, 4:00 PM ET

Key statistics

Day range
1.901.95
52-week range
1.803.06
Today
Open1.94
Previous close1.90
Volume29.9K
Valuation
Market cap21.08M
P/E ratio—
EPS (TTM)-1.49
Income & risk
Dividend / yield—
Beta0.18
Avg volume31.3K
Discussion

AYTU News

Stories mentioning AYTU from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue12,41115,16513,88815,13518,45216,22116,57414,593
Cost of Goods Sold4,8125,5414,7024,8815,6465,4354,5893,541
Gross Profit7,5999,6249,18610,25412,80610,78611,98511,052
Operating Expenses
Research & Development0.000.000.00216.00162.00522.00426.001,042
Sales General & Admin
Total Operating Expenses11,66311,59410,69017,87710,38512,48112,91513,325
Operating Income (Loss)(4,064)(1,970)(1,504)(7,623)2,421(1,695)(930.00)(2,273)
Interest Income
Interest Expense
Other Expense149.00190.00201.00(1,230)36.00140.00542.00120.00
Pretax Income(5,608)(10,584)1,965(19,443)3,818382.001,498(2,537)
Tax Provision10.000.000.00437.00(122.00)(283.00)405.00841.00
Net Income (Loss)(5,618)(10,584)1,965(19,818)3,994788.001,474(4,617)
Earnings Per Share (Basic)(0.53)(1.05)0.21(3.16)0.650.130.24(0.83)
Earnings Per Share (Diluted)(0.53)(1.05)(0.08)0.21(0.26)(0.15)
Weighted Average Shares Outstanding (Basic)10,51210,0369,4416,2806,1356,1326,0685,538
Weighted Average Shares Outstanding (Diluted)10,51210,03619,4778,2048,4859,100

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AYTU

Aytu BioPharma, Inc. (NASDAQ: AYTU) is a stock listed on the Nasdaq Stock Market under the ticker symbol AYTU. It last traded at $1.90 (Oct 27, 2026, 4:00 PM ET), down 1.6% on the day. That gives Aytu BioPharma a market capitalisation of $21.1M.

Over the past 52 weeks AYTU has traded between $1.80 and $3.06.

Revenue for the quarter ended Mar 31, 2026 was $12.4M; a net loss of $5.6M. Revenue was down 32.7% from $18.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$12.4M-$5.6M-45.3%
Dec 31, 2025$15.2M-$10.6M-69.8%
Sep 30, 2025$13.9M$2.0M14.1%
Jun 30, 2025$15.1M-$19.8M-130.9%

From Aytu BioPharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…